Medical - Care Facilities
Compare Stocks
2 / 10Stock Comparison
OPCH vs UNH
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
OPCH vs UNH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Care Facilities | Medical - Healthcare Plans |
| Market Cap | $3.20B | $333.37B |
| Revenue (TTM) | $5.67B | $449.71B |
| Net Income (TTM) | $206M | $12.04B |
| Gross Margin | 18.0% | 18.8% |
| Operating Margin | 5.9% | 4.2% |
| Forward P/E | 11.0x | 20.1x |
| Total Debt | $0.00 | $78.39B |
| Cash & Equiv. | $233M | $24.36B |
OPCH vs UNH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Option Care Health,… (OPCH) | 100 | 134.5 | +34.5% |
| UnitedHealth Group … (UNH) | 100 | 120.5 | +20.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: OPCH vs UNH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
OPCH carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.48
- Rev growth 13.0%, EPS growth 3.3%, 3Y rev CAGR 12.7%
- Lower volatility, beta 0.48, current ratio 1.53x
UNH is the clearest fit if your priority is long-term compounding.
- 220.3% 10Y total return vs OPCH's 92.2%
- 2.4% yield; 25-year raise streak; the other pay no meaningful dividend
- -4.7% vs OPCH's -37.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.0% revenue growth vs UNH's 11.8% | |
| Value | Lower P/E (11.0x vs 20.1x) | |
| Quality / Margins | 3.6% margin vs UNH's 2.7% | |
| Stability / Safety | Beta 0.48 vs UNH's 0.59 | |
| Dividends | 2.4% yield; 25-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -4.7% vs OPCH's -37.5% | |
| Efficiency (ROA) | 6.0% ROA vs UNH's 3.9%, ROIC 15.3% vs 9.2% |
OPCH vs UNH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
OPCH vs UNH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — OPCH and UNH each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 79.4x OPCH's $5.7B. Profitability is closely matched — net margins range from 3.6% (OPCH) to 2.7% (UNH).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $5.7B | $449.7B |
| EBITDAEarnings before interest/tax | $406M | $23.2B |
| Net IncomeAfter-tax profit | $206M | $12.0B |
| Free Cash FlowCash after capex | $244M | $19.7B |
| Gross MarginGross profit ÷ Revenue | +18.0% | +18.8% |
| Operating MarginEBIT ÷ Revenue | +5.9% | +4.2% |
| Net MarginNet income ÷ Revenue | +3.6% | +2.7% |
| FCF MarginFCF ÷ Revenue | +4.3% | +4.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.3% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +3.6% | +0.7% |
Valuation Metrics
OPCH leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 16.1x trailing earnings, OPCH trades at a 42% valuation discount to UNH's 27.8x P/E. On an enterprise value basis, OPCH's 7.3x EV/EBITDA is more attractive than UNH's 16.6x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.2B | $333.4B |
| Enterprise ValueMkt cap + debt − cash | $3.0B | $387.4B |
| Trailing P/EPrice ÷ TTM EPS | 16.10x | 27.76x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.96x | 20.06x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 7.26x | 16.61x |
| Price / SalesMarket cap ÷ Revenue | 0.57x | 0.74x |
| Price / BookPrice ÷ Book value/share | 2.52x | 3.29x |
| Price / FCFMarket cap ÷ FCF | 12.38x | 20.74x |
Profitability & Efficiency
OPCH leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
OPCH delivers a 15.3% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $12 for UNH. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs OPCH's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +15.3% | +11.5% |
| ROA (TTM)Return on assets | +6.0% | +3.9% |
| ROICReturn on invested capital | +15.3% | +9.2% |
| ROCEReturn on capital employed | +12.8% | +9.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | — | 0.77x |
| Net DebtTotal debt minus cash | -$233M | $54.0B |
| Cash & Equiv.Liquid assets | $233M | $24.4B |
| Total DebtShort + long-term debt | $0 | $78.4B |
| Interest CoverageEBIT ÷ Interest expense | 5.50x | 4.71x |
Total Returns (Dividends Reinvested)
UNH leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in OPCH five years ago would be worth $11,606 today (with dividends reinvested), compared to $9,746 for UNH. Over the past 12 months, UNH leads with a -4.7% total return vs OPCH's -37.5%. The 3-year compound annual growth rate (CAGR) favors UNH at -7.3% vs OPCH's -10.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -36.6% | +9.8% |
| 1-Year ReturnPast 12 months | -37.5% | -4.7% |
| 3-Year ReturnCumulative with dividends | -27.4% | -20.4% |
| 5-Year ReturnCumulative with dividends | +16.1% | -2.5% |
| 10-Year ReturnCumulative with dividends | +92.2% | +220.3% |
| CAGR (3Y)Annualised 3-year return | -10.1% | -7.3% |
Risk & Volatility
Evenly matched — OPCH and UNH each lead in 1 of 2 comparable metrics.
Risk & Volatility
OPCH is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 90.7% from its 52-week high vs OPCH's 55.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.48x | 0.59x |
| 52-Week HighHighest price in past year | $36.80 | $404.72 |
| 52-Week LowLowest price in past year | $18.01 | $234.60 |
| % of 52W HighCurrent price vs 52-week peak | +55.6% | +90.7% |
| RSI (14)Momentum oscillator 0–100 | 24.4 | 74.5 |
| Avg Volume (50D)Average daily shares traded | 2.4M | 8.1M |
Analyst Outlook
UNH leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates OPCH as "Buy" and UNH as "Buy". Consensus price targets imply 61.4% upside for OPCH (target: $33) vs 4.9% for UNH (target: $385). UNH is the only dividend payer here at 2.37% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $33.00 | $385.43 |
| # AnalystsCovering analysts | 14 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | +2.4% |
| Dividend StreakConsecutive years of raises | 1 | 25 |
| Dividend / ShareAnnual DPS | — | $8.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +9.7% | +1.7% |
OPCH leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). UNH leads in 2 (Total Returns, Analyst Outlook). 2 tied.
OPCH vs UNH: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is OPCH or UNH a better buy right now?
For growth investors, Option Care Health, Inc.
(OPCH) is the stronger pick with 13. 0% revenue growth year-over-year, versus 11. 8% for UnitedHealth Group Incorporated (UNH). Option Care Health, Inc. (OPCH) offers the better valuation at 16. 1x trailing P/E (11. 0x forward), making it the more compelling value choice. Analysts rate Option Care Health, Inc. (OPCH) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — OPCH or UNH?
On trailing P/E, Option Care Health, Inc.
(OPCH) is the cheapest at 16. 1x versus UnitedHealth Group Incorporated at 27. 8x. On forward P/E, Option Care Health, Inc. is actually cheaper at 11. 0x.
03Which is the better long-term investment — OPCH or UNH?
Over the past 5 years, Option Care Health, Inc.
(OPCH) delivered a total return of +16. 1%, compared to -2. 5% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: UNH returned +220. 3% versus OPCH's +92. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — OPCH or UNH?
By beta (market sensitivity over 5 years), Option Care Health, Inc.
(OPCH) is the lower-risk stock at 0. 48β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately 23% more volatile than OPCH relative to the S&P 500.
05Which is growing faster — OPCH or UNH?
By revenue growth (latest reported year), Option Care Health, Inc.
(OPCH) is pulling ahead at 13. 0% versus 11. 8% for UnitedHealth Group Incorporated (UNH). On earnings-per-share growth, the picture is similar: Option Care Health, Inc. grew EPS 3. 3% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, OPCH leads at 12. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — OPCH or UNH?
Option Care Health, Inc.
(OPCH) is the more profitable company, earning 3. 7% net margin versus 2. 7% for UnitedHealth Group Incorporated — meaning it keeps 3. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OPCH leads at 6. 0% versus 4. 2% for UNH. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is OPCH or UNH more undervalued right now?
On forward earnings alone, Option Care Health, Inc.
(OPCH) trades at 11. 0x forward P/E versus 20. 1x for UnitedHealth Group Incorporated — 9. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OPCH: 61. 4% to $33. 00.
08Which pays a better dividend — OPCH or UNH?
In this comparison, UNH (2.
4% yield) pays a dividend. OPCH does not pay a meaningful dividend and should not be held primarily for income.
09Is OPCH or UNH better for a retirement portfolio?
For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
59), 2. 4% yield, +220. 3% 10Y return). Both have compounded well over 10 years (UNH: +220. 3%, OPCH: +92. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between OPCH and UNH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: OPCH is a small-cap deep-value stock; UNH is a large-cap quality compounder stock. UNH pays a dividend while OPCH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.